Baillie Gifford trim Vertex Pharmaceuticals Inc
Baillie Gifford trim $60.3M of disclosed value in Vertex Pharmaceuticals Inc.
Signal
Investor Move
Action
Trim
Capital
$60.3M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.